{
    "Orphapacket": {
        "ORPHApacketId": "55880",
        "creationDate": "2025-12-09 10:41:42",
        "version": "1.3.42 / 4.1.8 [2025-03-03]",
        "copyright": "Orphanet (c) 2025",
        "ORPHAcode": "55880",
        "Label": "Chondrosarcoma",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_55880",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "215300",
                "DisorderMappingRelation": "E (Exact mapping: the two concepts are equivalent)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "Chondrosarcoma is a malignant bone tumor arising from cartilaginous tissue most frequently occuring at the ends of the femur and tibia the proximal end of the humerus and the pelvis; and presenting with a palpable mass and progressive pain. Chondrosarcoma is usually slow growing at low histological grades and can be well managed by intralesional curettage or en-block wide resection."
        },
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "223727",
                        "Label": "Bone sarcoma"
                    }
                ]
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Europe"
                }
            },
            {
                "Prevalence": {
                    "Source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "1-9 / 100 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Europe"
                }
            },
            {
                "Prevalence": {
                    "Source": "22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Lifetime Prevalence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 100 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Europe"
                }
            }
        ],
        "AverageAgeOfOnsets": {
            "AverageAgeOfOnset": [
                {
                    "value": "Adult"
                }
            ]
        },
        "TypeOfInheritances": [
            {
                "TypeOfInheritance": {
                    "value": "Not applicable"
                }
            },
            {
                "TypeOfInheritance": {
                    "value": "Unknown"
                }
            }
        ]
    }
}